Adamas Pharmaceuticals, Inc. ADMS

Adamas Pharmaceuticals, Inc. DIO Ratio 2011-2026 | ADMS

Annual DIO Ratio Adamas Pharmaceuticals, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.31 K	779	2.95 K	36.6 K	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
36.6 K	779	10.4 K

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Amphastar Pharmaceuticals AMPH	166	$ 21.6	1.12 %	$ 1.01 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Akebia Therapeutics AKBA	147	$ 1.54	4.77 %	$ 396 M	USA
	Aquestive Therapeutics AQST	120	$ 4.2	0.24 %	$ 449 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 25.23	4.6 %	$ 3.21 B	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.49	1.02 %	$ 397 M	Britain
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain